DOI QR코드

DOI QR Code

난소절제 흰쥐에서 엉겅퀴 추출물의 골다공증 보호 효과

Osteoprotective Effect of Extract from Cirsium japonicum var. ussuriense in Ovariectomized Rats

  • 김영옥 (농촌진흥청 국립원예특작과학원 인삼특작부) ;
  • 김진성 (농촌진흥청 국립원예특작과학원 인삼특작부) ;
  • 이상원 (농촌진흥청 국립원예특작과학원 인삼특작부) ;
  • 조익현 (농촌진흥청 국립원예특작과학원 인삼특작부) ;
  • 나세원 (전북대학교 수의과대학)
  • Kim, Young Ock (Department of Herbal Crop Research, NIHHS, RDA) ;
  • Kim, Jin Seong (Department of Herbal Crop Research, NIHHS, RDA) ;
  • Lee, Sang Won (Department of Herbal Crop Research, NIHHS, RDA) ;
  • Jo, Ick Hyun (Department of Herbal Crop Research, NIHHS, RDA) ;
  • Na, Sae Won (College of Veterinary Medicine, Chonbuk National University)
  • 투고 : 2014.11.28
  • 심사 : 2014.01.07
  • 발행 : 2015.02.28

초록

This study was carried out to investigate the effects of the Cirsium japonicum var. ussuriense (C. japonicum) extract on serum level of hormones from induced osteoporosis by ovariectomized rats. Two month-old rats were ovariectomized (OVX), remained untreated for 8 weeks, and were subsequently administered C. japonicum (200 mg/kg) every day for 8 weeks. We examined the effects of treated C. japonicum on ovariectomy-related changes in Insulin-like Growth Factors (IGF), Insulin-like Growth Factor binding protein-3 (IGBF-3), Estrogen, Calcium, and Phosporus. After 8 weeks, the serum levels of IGF-I, -II, and IGFBP-3 were higher presented as compared to the other two groups (P < 0.05), in the C. japonicum extract treatment on OVX rats. There were differences between OVX and C. japonicum extract treated OVX rats in serum levels of $Ca^{2+}$, but $Ca^{2+}$ levels for the normal group was higher than for the other two groups. The C. japonicum extract increased both serum IGFs and IGFBP-3 levels on induced osteoporotic rat by ovariectomized. Thus, these results revealed that the C. japonicum extract is a possible role for improvement of osteoporosis induced-ovariectomized rats and has a great potential as an alternative tool for the treatment of osteoporosis.

키워드

참고문헌

  1. Ammann P, Rizzoli R, Meyer JM and Bonjour JP. (1996). Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariecto-mized rats. Osteoporos International. 6:219-227.
  2. Baxter RC. (1993). Circulating binding proteins for the insulin like growth factors. Trends in Endocrinology and Metabolism. 4:91-96. https://doi.org/10.1016/1043-2760(93)90085-S
  3. Binoux M and Hossenlopp P. (1988). Insulin-like growth factor(IGF) and IGF-binding proteins: Comparison of human serum and lymph. Journal of Clinical Endocrinolgy Metabolism. 67:509-14. https://doi.org/10.1210/jcem-67-3-509
  4. Christiansen C. (1993). Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. The American Journal of Medicine. 94:646-650. https://doi.org/10.1016/0002-9343(93)90218-E
  5. Chung HY, Sung B, Jung KJ, Zou Y and Yu BP. (2006). The molecular inflammatory process in aging. Antioxidant & Redox Signaling. 18:572-581.
  6. Dang ZC, Van Bezooijen RL, Karperien M, Papapoulos SE and Lowik CW. (2002). Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. Journal of Bone and Mineral Research. 17:394-405. https://doi.org/10.1359/jbmr.2002.17.3.394
  7. Dinielsen CC and Flyvbjerg A. (1996). Insulin-like growth Factor I as a predictor of cortical bone mass a long-term study of ovariectomized an estrogen-treated rats. Bone. 19:493-498. https://doi.org/10.1016/S8756-3282(96)00256-6
  8. Epstein S. (2006). Epstein update of current therapeutic options for the treatment of postmenopausal osteoporosis. Clinical Therapeutics. 28:151-173. https://doi.org/10.1016/j.clinthera.2006.02.007
  9. Jiang J, Lichtler AC and Gronowicz GA. (2006). Transgenic mice with osteoblast targeted insulin-like growth factor-I show increased bone remodeling. Bone. 39:494-504. https://doi.org/10.1016/j.bone.2006.02.068
  10. Jiro F, Shumpei N, Yuji Y, Akira Y and Mitsuo O. (2011). Wear debris stimulates bone-resorbing factor expression in the fibroblasts and osteoblasts. Hip International. 21:231-237. https://doi.org/10.5301/HIP.2011.7977
  11. Juul A. (2001). The effects of oestrogens on linear bone growth. Human Reproduction Update. 7:303-313. https://doi.org/10.1093/humupd/7.3.303
  12. Kim DY, Kang SH and Ghil SH. (2010). Cirsium japonicum extract induces apoptosis and anti-proliferation in the human breast cancer cell line MCF-7. Molecular Medicine Reports. 3:427-432.
  13. Kim SH, Ku SY and Jee BC. (2003b). Clinical efficacy of serum insulin-like growth factor-I(IGF-I), IGF-II, and IGF binding protein-3(IGFBP-3) in predicting the prognosis of in vitro fertilization and embryo transfer. Korean Journal of Obstetrics & Gynecology. 46:802-809.
  14. Koch H, Jadlowiec JA and Campbell PG. (2005). Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells and Development. 14:621-631. https://doi.org/10.1089/scd.2005.14.621
  15. Lee HK, Kim JS, Kim NY, Kim MJ, Park SU and Yu CY. (2003). Antioxidant, antimutagenicity and anticancer activities of extracts from Cirsium japonicum var. ussuriense KITAMURA. Korean Journal of Medicinal Crop Science. 11:53-61.
  16. McLean RR. (2009). Proinflammatory cytokines and osteoporosis. Current Osteoporosis Reports. 7:134-139. https://doi.org/10.1007/s11914-009-0023-2
  17. Nasu M, Sugimoto T, Chihara M, Hiraumi M, Kurimoto F and Chihara K. (1997). Effect of natural menopause on serum levels of IGF-I and IGF-binding protein : Relationship with bone mineral density and lipid metabolism in perimenopausal woman. European Journal of Endocrinology. 136:608-616. https://doi.org/10.1530/eje.0.1360608
  18. Nilsson A, Ohlsson C, Isaksson OG, Lindahl A and Isgaard J. (1994). Hormonal regulation of longitudinal bone growth. European Journal of Clinical Nutrition. 48:150-158.
  19. Park MK, Rhyu MR, Yoon BK, Kwon H, Jang S and Lee YJ. (2008). Modulation of the genomic estrogen receptor pathway by water extracts of Cirsium japonicum. Archives of Pharmacal Research. 31:225-230. https://doi.org/10.1007/s12272-001-1145-y
  20. Park YC, Lee JS, Kim DY, Son HY, Lee JW, Cheoi YS, Kim KK, Yu CY, Chung IM, Im MH, Lee KJ, Choi RN, Shim HS and Lim JD. (2013). A 90 day repeated dose-oral toxicity study of extracts from Astragalus membranaceus-aboveground parts in rats. Korean Journal of Medicinal Crop Science. 21:474-485. https://doi.org/10.7783/KJMCS.2013.21.6.474
  21. Roith DL, Bondy C, Yakar S, Liu JL and Butler A. (2001). The somatomedin hypothesis. Endocrine Reviews. 22:53-74. https://doi.org/10.1210/edrv.22.1.0419
  22. Rosen CJ, Donahue LR and Hunter SJ. (1994). Insulin-like growth factors and bone: the osteoporosis connection. Proceedings of the Society for Experimental Biology and Medicine. 206:83-102. https://doi.org/10.3181/00379727-206-43726
  23. Rosen CJ and Pollak M. (1999). Circulating IGF-I: New perspectives for a new century. Trends in Endocrinology and Metabolism. 10:136-141. https://doi.org/10.1016/S1043-2760(98)00126-X
  24. Stewart CE and Rotwein P. (1996). Growth, differentiation and survival: Multiple physiological functions for insulin-like growth factors. Physiological Reviews. 76:1005-1026. https://doi.org/10.1152/physrev.1996.76.4.1005
  25. Turner RT, Maran A, Lotinun S, Hefferan T, Evans GL, Zhang M and Sibonga JD. (2001). Animal models for osteoporosis. Review of Endocrinology and Metabolism. 2:117-127.
  26. Yakar S, Rosen CJ and Beamer WG. (2002). Circulating levels of IGF-I directly regulate bone growth and density. Journal of Clinical Investigation. 110:771-781. https://doi.org/10.1172/JCI0215463
  27. Yin J, Heo SI and Wang MH. (2008). Antioxidant and antidiabetic activities of extracts from Cirsium japonicum roots. Nutrition Research Practice. 2:247-251. https://doi.org/10.4162/nrp.2008.2.4.247

피인용 문헌

  1. Flavonoids from Cirsium japonicum var. maackii pappus as inhibitors of aldose reductase and their simultaneous determination 2018, https://doi.org/10.1007/s11696-017-0259-8